Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carbocyclic nucleoside reverse transcriptase inhibitors

Carbocyclic nucleoside reverse transcriptase inhibitors

US Patent 11040975 · Granted Jun 22, 2021

Estimated economic value: $110,392,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic heterocycle compounds methods of use thereof for the treatment of herpe2025
Pro drugs of PDE10 compounds2025
Pro drugs of PDE10 compounds2024
Phosphinic amide prodrugs of tenofovir2023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2022
Antiviral benzyl-amine phosphodiamide compounds2021
Cyclic phosphate substituted nucleoside compounds and methods of use thereof for2021
Nucleotides for the treatment of cancer2020
Substituted quinolizine derivatives useful as HIV integrase inhibitors2020
Nucleotides for the treatment of cancer2020
Antiviral phosphodiamide prodrugs of tenofovir2020